US Patent Issued to The Board of Regents of The University of Texas System on Aug. 18 for "Cancer treatment through RLIP76 partial depletion" (Texas Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,746, issued on Aug. 18, was assigned to The Board of Regents of The University of Texas System.

"Cancer treatment through RLIP76 partial depletion" was invented by Sanjay Awasthi (Lubbock, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Partial depletion of RLIP76 in p53 deficient living subject has shown many health benefits. In one embodiment, partical Rlip depletion is used to prevent or treat cancer in p53 deficient living subjects. In another embodiment, partial Rlip depletion is used for reversion of DNA-methylation abnormalities caused by the lack of p53 to normal in p53 deficient living subjects. In yet another embodiment, partial Rlip ...